WVE
Income statement / Annual
Last year (2023), Wave Life Sciences Ltd.'s total revenue was $113.31 M,
an increase of 3,005.10% from the previous year.
In 2023, Wave Life Sciences Ltd.'s net income was -$57.51 M.
See Wave Life Sciences Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$113.31 M
|
$3.65 M
|
$40.96 M
|
$20.08 M
|
$15.98 M
|
$14.41 M
|
$3.70 M
|
$1.49 M
|
$152,000.00
|
$0.00
|
| Cost of Revenue |
$9.21 M |
$10.11 M |
$121.88 M |
$124.17 M |
$175.43 M |
$134.43 M |
$79.31 M |
$393,000.00 |
$9.06 M |
$2.40 M |
| Gross Profit |
$104.10 M |
-$6.47 M |
-$80.91 M |
-$104.09 M |
-$159.45 M |
-$120.01 M |
-$75.61 M |
$1.09 M |
-$8.91 M |
-$2.40 M |
| Gross Profit Ratio |
0.92 |
-1.77 |
-1.98 |
-5.18 |
-9.98 |
-8.33 |
-20.41 |
0.74 |
-58.59 |
0 |
| Research and Development
Expenses |
$130.01 M
|
$115.86 M
|
$121.88 M
|
$130.94 M
|
$175.43 M
|
$134.43 M
|
$79.31 M
|
$40.82 M
|
$9.06 M
|
$2.40 M
|
| General & Administrative
Expenses |
$51.29 M
|
$50.51 M
|
$46.11 M
|
$42.51 M
|
$48.87 M
|
$39.51 M
|
$26.98 M
|
$15.99 M
|
$10.39 M
|
$3.00 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$51.29 M
|
$50.51 M
|
$46.11 M
|
$42.51 M
|
$48.87 M
|
$39.51 M
|
$26.98 M
|
$15.99 M
|
$10.39 M
|
$3.00 M
|
| Other Expenses |
$0.00 |
$7,000.00 |
$4.54 M |
$2.06 M |
$9.74 M |
$9.55 M |
-$331,000.00 |
-$50,000.00 |
$56,000.00 |
$261,000.00 |
| Operating Expenses |
$181.30 M |
$166.37 M |
$167.98 M |
$173.45 M |
$224.30 M |
$173.94 M |
$106.28 M |
$56.81 M |
$19.45 M |
$5.39 M |
| Cost And Expenses |
$181.30 M |
$166.37 M |
$167.98 M |
$173.45 M |
$224.30 M |
$173.94 M |
$106.28 M |
$56.81 M |
$19.45 M |
$5.39 M |
| Interest Income |
$7.93 M |
$0.00 |
$30,000.00 |
$568,000.00 |
$4.94 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$16,000.00 |
$0.00 |
$22,000.00 |
$6,000.00 |
$337,000.00 |
$86,000.00 |
$12,000.00 |
| Depreciation &
Amortization |
$9.21 M
|
$10.11 M
|
$9.84 M
|
$9.98 M
|
$9.20 M
|
$5.58 M
|
$2.16 M
|
$784,000.00
|
$594,000.00
|
$281,000.00
|
| EBITDA |
-$58.79 M
|
-$152.61 M
|
-$117.18 M
|
-$143.39 M
|
-$200.73 M
|
-$153.94 M
|
-$100.24 M
|
-$54.94 M
|
-$18.56 M
|
-$5.11 M
|
| EBITDA Ratio |
-0.52 |
-44.59 |
-3.1 |
-7.67 |
-13.34 |
-10.91 |
-27.54 |
-37.43 |
-123.05 |
0 |
| Operating Income Ratio
|
-0.6
|
-44.59
|
-3.1
|
-7.64
|
-13.03
|
-11.07
|
-27.69
|
-37.26
|
-126.96
|
0
|
| Total Other
Income/Expenses Net |
$9.81 M
|
$1.58 M
|
$4.57 M
|
$2.63 M
|
$14.68 M
|
$12.94 M
|
$1.25 M
|
$542,000.00
|
$142,000.00
|
$249,000.00
|
| Income Before Tax |
-$58.19 M |
-$161.14 M |
-$122.45 M |
-$150.75 M |
-$193.64 M |
-$146.58 M |
-$101.33 M |
-$54.79 M |
-$19.16 M |
-$5.15 M |
| Income Before Tax Ratio
|
-0.51
|
-44.16
|
-2.99
|
-7.51
|
-12.12
|
-10.17
|
-27.36
|
-36.89
|
-126.03
|
0
|
| Income Tax Expense |
-$677,000.00 |
$681,000.00 |
-$204,000.00 |
-$841,000.00 |
-$14.14 M |
$69,000.00 |
$708,000.00 |
$616,000.00 |
$44,000.00 |
$84,000.00 |
| Net Income |
-$57.51 M |
-$161.82 M |
-$122.25 M |
-$149.91 M |
-$179.50 M |
-$146.65 M |
-$102.04 M |
-$55.40 M |
-$19.20 M |
-$5.23 M |
| Net Income Ratio |
-0.51 |
-44.35 |
-2.98 |
-7.47 |
-11.23 |
-10.17 |
-27.55 |
-37.31 |
-126.32 |
0 |
| EPS |
-0.54 |
-2.05 |
-2.36 |
-3.82 |
-5.3 |
-5.06 |
-3.85 |
-2.43 |
-1.83 |
-0.25 |
| EPS Diluted |
-0.54 |
-2.05 |
-2.36 |
-3.82 |
-5.3 |
-5.06 |
-3.85 |
-2.43 |
-1.83 |
-0.25 |
| Weighted Average Shares
Out |
$106.10 M
|
$78.86 M
|
$51.83 M
|
$39.23 M
|
$33.87 M
|
$28.97 M
|
$26.51 M
|
$22.80 M
|
$10.50 M
|
$20.93 M
|
| Weighted Average Shares
Out Diluted |
$106.10 M
|
$78.86 M
|
$51.83 M
|
$39.23 M
|
$33.87 M
|
$28.97 M
|
$26.51 M
|
$22.80 M
|
$10.50 M
|
$20.93 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
